A flavone constituent from myoporum bontioides induces M-phase cell cycle arrest of MCF-7 breast cancer cells

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Myoporum bontioides is a traditional medicinal plant in Asia with various biological activities, including anti-inflammatory and anti-bacterial characteristics. To identify the bioactive constituents from M. bontioides, a newly-identified flavone, 3,4'-dimethoxy-3',5,7-trihydroxyflavone (compound 1), along with eight known compounds, were investigated in human MCF-7 breast cancer, SCC4 oral cancer, and THP-1 monocytic leukemia cells. Among these compounds, compound 1 exhibited the strongest antiproliferative activity with half-maximal inhibitory concentration (IC50) values ranging from 3.3 μ M (MCF-7) to 8.6 μ M (SCC4). Flow cytometric analysis indicated that compound 1 induced G2/M cell cycle arrest in MCF-7 cells. Mechanistic evidence suggests that the G2/M arrest could be attributable to compound 1's modulatory effects on the phosphorylation and expression of numerous key signaling effectors, including cell division cycle 2 (CDC2), CDC25C, and p53. Notably, compound 1 downregulated the expression of histone deacetylase 2 (HDAC2) and HDAC4, leading to increased histone H3 acetylation and p21 upregulation. Together, these findings suggest the translational potential of compound 1 as a breast cancer treatment.

Cite

CITATION STYLE

APA

Weng, J. R., Bai, L. Y., Lin, W. Y., Chiu, C. F., Chen, Y. C., Chao, S. W., & Feng, C. H. (2017). A flavone constituent from myoporum bontioides induces M-phase cell cycle arrest of MCF-7 breast cancer cells. Molecules, 22(3). https://doi.org/10.3390/molecules22030472

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free